We are monitoring the impact of COVID-19 on APAC Insulin Delivery Devices Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 229
Share on
Share on

Asia Pacific Insulin Delivery Devices Market Analysis - By Type, Application, Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Analysis on Size, Share, Trends, Growth, Forecast (2020 to 2025)

Pulished: February, 2020
ID: 229
Pages: 145

APAC Insulin Delivery Devices Market Size (2020 to 2025)

The size of the insulin delivery devices market in the Asia Pacific is projected to grow USD 4.26 billion by 2025 from USD 3.12 billion in 2020, witnessing a growth rate of 6.40% from 2020 to 2025.

Insulin maintains the sugar levels in the blood and essential for the people who have type I diabetes & type II diabetes. The development of insulin delivery devices has been encouraged in the past years. These devices are used to deliver insulin doses via the parenteral route rather than the oral route of administration. Insulin delivery devices promote the absorption rate of insulin into the bloodstream from the site of injection to execute immediate pharmacological action of insulin. Some of the majorly used insulin delivery devices, such as insulin syringes, insulin pens, insulin pen needles, insulin pumps, and insulin jet injectors.

The rising number of pre-diabetic & large diabetic patient population, growing distribution networks of foreign manufacturers in this region, presence of favorable regulatory frameworks, availability of significant medical reimbursements, and increasing expansions of advanced medical facilities in certain Asian countries (China & India) are driving the growth of insulin delivery devices market in Asia-Pacific region.

However, low adoption of advanced diabetic technology products, high cost of the manufacturing of products, and lack awareness of diabetic patients about the advanced diabetic treatment solutions are restraining the growth of the insulin delivery devices market in the Asia-Pacific region.

This research report segmented and sub-segmented into the following categories:

  • By Type: Insulin Syringes, Insulin Pens, Insulin Pen Needles, Insulin Pumps And Insulin Jet Injectors
  • By Application: Type I Diabetes, Type II Diabetes
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Based on type, the insulin syringes segment commanded the largest share of the Asia Pacific insulin delivery devices market in 2019. In contrast, the insulin pens segment is estimated to grow at the highest CAGR during the forecast period 2019-2024.

Companies playing a dominant role in the Asia Pacific Insulin Delivery Devices Market profiled in this report are Becton, Dickinson, and Company (U.S.), Sanofi (France), Novo Nordisk A/S (Denmark), Julphar (U.A.E.), Eli Lilly and Company (U.S.), Biocon Ltd. (India), Ypsomed AG (Switzerland), Wockhardt Ltd. (India), B. Braun Meselgen AG (Switzerland) and Biodel Inc. (U.S.).

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Introduction                                                               

                5.2 Type                                                              

                                5.2.1 Introduction                                           

                                5.2.2 Insulin Syringes                                     

                                5.2.3 Insulin Pens                                            

                                5.2.4 Insulin Pen Needles                                            

                                5.2.5 Insulin Pumps                                        

                                5.2.6 Insulin Jet Injectors                                             

                5.3 Application                                                 

                                5.3.1 Introduction                                           

                                5.3.2 Type I Diabetes                                     

                                5.3.3 Type II Diabetes                                    

6. Geographical Analysis                                                                              

                6.3 Asia-Pacific                                                 

                                6.3.1 Introduction                                           

                                6.3.2 China                                         

                                6.3.3 India                                          

                                6.3.4 Japan                                         

                                6.3.5 Australia                                   

                                6.3.6 Soth Korea                                              

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Sanofi (France)                                                         

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Novo Nordisk A/S (Denmark)                                                             

                8.3 Eli Lilly and Company (U.S.)                                                  

                8.4 Biocon Ltd. (India)                                                   

                8.5 Julphar (U.A.E.)                                                        

                8.6 Ypsomed AG (Switzerland)                                                  

                8.7 Becton, Dickinson and Company (U.S.)                                                          

                8.8 Wockhardt Ltd. (India)                                                           

                8.9 B. Braun Meselgen AG (Switzerland)                                                              

                8.10 Biodel Inc. (U.S.)                                                    

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Expert Opinions                                                                        

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Insulin Delivery Devices Market, By Region, From 2020 to 2025 (USD Million)
  2. Asia-Pacific Insulin Delivery Devices Market, By Type, From 2020 to 2025 (USD Million)
  3. Asia-Pacific Insulin Syringes Market, By Region, From 2020 to 2025 (USD Million)
  4. Asia-Pacific Insulin Pens Market, By Region, From 2020 to 2025 (USD Million)
  5. Asia-Pacific Insulin Pen Needles Market, By Region, From 2020 to 2025 (USD Million)
  6. Asia-Pacific Insulin Pumps Market, By Region, From 2020 to 2025 (USD Million)
  7. Asia-Pacific Insulin Jet Injectors Market, By Region, From 2020 to 2025 (USD Million)
  8. Asia-Pacific Insulin Delivery Devices Market, By Application, From 2020 to 2025 (USD Million)
  9. Asia-Pacific Type I Diabetes of Insulin Delivery Devices Market, By Region, From 2020 to 2025 (USD Million)
  10. Asia-Pacific Type II Diabetes of Insulin Delivery Devices Market, By Region, From 2020 to 2025 (USD Million)
  11. China Insulin Delivery Devices Market, By Type, From 2020 to 2025 (USD Million)
  12. China Insulin Delivery Devices Market, By Application, From 2020 to 2025 (USD Million)
  13. India Insulin Delivery Devices Market, By Type, From 2020 to 2025 (USD Million)
  14. India Insulin Delivery Devices Market, By Application, From 2020 to 2025 (USD Million)
  15. Japan Insulin Delivery Devices Market, By Type, From 2020 to 2025 (USD Million)
  16. Japan Insulin Delivery Devices Market, By Application, From 2020 to 2025 (USD Million)
  17. Australia Insulin Delivery Devices Market, By Type, From 2020 to 2025 (USD Million)
  18. Australia Insulin Delivery Devices Market, By Application, From 2020 to 2025 (USD Million)
  19. South Korea Insulin Delivery Devices Market, By Type, From 2020 to 2025 (USD Million)
  20. South Korea Insulin Delivery Devices Market, By Application, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample